Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1): Potential implications on future therapeutic intervention

So Young Kim, Ah Reum Kim, Nayoung K D Kim, Chung Lee, Jin Hee Han, Min Young Kim, Eun Hee Jeon, Woong Yang Park, Rahul Mittal, Denise Yan, Xue Z Liu, Byung Yoon Choi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The symptoms of phosphoribosyl pyrophosphate synthetase 1 (PRPS1) deficiency diseases have been reported to be alleviated by medication. In the present study, we report biochemical data that favor PRPS1 deficiency-related hearing loss as a potential target for pharmaceutical treatment. Methods: We recruited 42 probands from subjects aged less than 15 years with a moderate degree of nonsyndromic autosomal-recessive or sporadic sensorineural hearing loss (SNHL) in at least one side. Molecular genetic testing, including targeted exome sequencing (TES) of 129 genes for deafness, and in silico prediction were performed. Results: A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in X-linked recessive inheritance from one Korean multiplex SNHL family. Subsequent measurement of in vitro enzymatic activities of PRPS1 from erythrocytes of affected and unaffected family members, as well as unrelated normal controls, confirmed a pathogenic role of this variant. In detail, compared to normal hearing controls (0.23–0.26 nmol/ml/h), the proband, the affected sibling and their normal hearing mother demonstrated a significantly decreased PRPS1 enzymatic activity (0.07, 0.03 and 0.11 nmol/ml/h, respectively). This novel loss-of-function mutation of PRPS1 (p.A82P) is the ninth and sixth most reported mutation in the world and in Asia, respectively. Conclusions: DFNX1 was found to account for approximately 2.4% (1/42) of moderate SNHL in a Korean pediatric population. Confirmation of PRPS1 activity deficiency and an audiologic phenotype that initially begins in a milder form of SNHL, as in our family, should indicate the need for rigorous genetic screening as early as possible.

Original languageEnglish (US)
Pages (from-to)353-358
Number of pages6
JournalJournal of Gene Medicine
Volume18
Issue number11-12
DOIs
StatePublished - Nov 1 2016

Fingerprint

Ribose-Phosphate Pyrophosphokinase
Sensorineural Hearing Loss
Mutation
Genetic Testing
Therapeutics
Hearing
Exome
Deficiency Diseases
X-Linked Genes
Deafness
Nonsyndromic Deafness
Hearing Loss
Computer Simulation
Siblings
Molecular Biology
Erythrocytes
Mothers
Pediatrics
Phenotype

Keywords

  • DFNX1 (X-linked nonsyndromic sensorineural deafness type 1)
  • Korean
  • p.A82P
  • PRPS1
  • S-adenosylmethionine (SAM)

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Cite this

Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1) : Potential implications on future therapeutic intervention. / Kim, So Young; Kim, Ah Reum; Kim, Nayoung K D; Lee, Chung; Han, Jin Hee; Kim, Min Young; Jeon, Eun Hee; Park, Woong Yang; Mittal, Rahul; Yan, Denise; Liu, Xue Z; Choi, Byung Yoon.

In: Journal of Gene Medicine, Vol. 18, No. 11-12, 01.11.2016, p. 353-358.

Research output: Contribution to journalArticle

Kim, So Young ; Kim, Ah Reum ; Kim, Nayoung K D ; Lee, Chung ; Han, Jin Hee ; Kim, Min Young ; Jeon, Eun Hee ; Park, Woong Yang ; Mittal, Rahul ; Yan, Denise ; Liu, Xue Z ; Choi, Byung Yoon. / Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1) : Potential implications on future therapeutic intervention. In: Journal of Gene Medicine. 2016 ; Vol. 18, No. 11-12. pp. 353-358.
@article{e7e923e1697049c69733b68c5546b68e,
title = "Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1): Potential implications on future therapeutic intervention",
abstract = "Background: The symptoms of phosphoribosyl pyrophosphate synthetase 1 (PRPS1) deficiency diseases have been reported to be alleviated by medication. In the present study, we report biochemical data that favor PRPS1 deficiency-related hearing loss as a potential target for pharmaceutical treatment. Methods: We recruited 42 probands from subjects aged less than 15 years with a moderate degree of nonsyndromic autosomal-recessive or sporadic sensorineural hearing loss (SNHL) in at least one side. Molecular genetic testing, including targeted exome sequencing (TES) of 129 genes for deafness, and in silico prediction were performed. Results: A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in X-linked recessive inheritance from one Korean multiplex SNHL family. Subsequent measurement of in vitro enzymatic activities of PRPS1 from erythrocytes of affected and unaffected family members, as well as unrelated normal controls, confirmed a pathogenic role of this variant. In detail, compared to normal hearing controls (0.23–0.26 nmol/ml/h), the proband, the affected sibling and their normal hearing mother demonstrated a significantly decreased PRPS1 enzymatic activity (0.07, 0.03 and 0.11 nmol/ml/h, respectively). This novel loss-of-function mutation of PRPS1 (p.A82P) is the ninth and sixth most reported mutation in the world and in Asia, respectively. Conclusions: DFNX1 was found to account for approximately 2.4{\%} (1/42) of moderate SNHL in a Korean pediatric population. Confirmation of PRPS1 activity deficiency and an audiologic phenotype that initially begins in a milder form of SNHL, as in our family, should indicate the need for rigorous genetic screening as early as possible.",
keywords = "DFNX1 (X-linked nonsyndromic sensorineural deafness type 1), Korean, p.A82P, PRPS1, S-adenosylmethionine (SAM)",
author = "Kim, {So Young} and Kim, {Ah Reum} and Kim, {Nayoung K D} and Chung Lee and Han, {Jin Hee} and Kim, {Min Young} and Jeon, {Eun Hee} and Park, {Woong Yang} and Rahul Mittal and Denise Yan and Liu, {Xue Z} and Choi, {Byung Yoon}",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/jgm.2935",
language = "English (US)",
volume = "18",
pages = "353--358",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "11-12",

}

TY - JOUR

T1 - Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1)

T2 - Potential implications on future therapeutic intervention

AU - Kim, So Young

AU - Kim, Ah Reum

AU - Kim, Nayoung K D

AU - Lee, Chung

AU - Han, Jin Hee

AU - Kim, Min Young

AU - Jeon, Eun Hee

AU - Park, Woong Yang

AU - Mittal, Rahul

AU - Yan, Denise

AU - Liu, Xue Z

AU - Choi, Byung Yoon

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background: The symptoms of phosphoribosyl pyrophosphate synthetase 1 (PRPS1) deficiency diseases have been reported to be alleviated by medication. In the present study, we report biochemical data that favor PRPS1 deficiency-related hearing loss as a potential target for pharmaceutical treatment. Methods: We recruited 42 probands from subjects aged less than 15 years with a moderate degree of nonsyndromic autosomal-recessive or sporadic sensorineural hearing loss (SNHL) in at least one side. Molecular genetic testing, including targeted exome sequencing (TES) of 129 genes for deafness, and in silico prediction were performed. Results: A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in X-linked recessive inheritance from one Korean multiplex SNHL family. Subsequent measurement of in vitro enzymatic activities of PRPS1 from erythrocytes of affected and unaffected family members, as well as unrelated normal controls, confirmed a pathogenic role of this variant. In detail, compared to normal hearing controls (0.23–0.26 nmol/ml/h), the proband, the affected sibling and their normal hearing mother demonstrated a significantly decreased PRPS1 enzymatic activity (0.07, 0.03 and 0.11 nmol/ml/h, respectively). This novel loss-of-function mutation of PRPS1 (p.A82P) is the ninth and sixth most reported mutation in the world and in Asia, respectively. Conclusions: DFNX1 was found to account for approximately 2.4% (1/42) of moderate SNHL in a Korean pediatric population. Confirmation of PRPS1 activity deficiency and an audiologic phenotype that initially begins in a milder form of SNHL, as in our family, should indicate the need for rigorous genetic screening as early as possible.

AB - Background: The symptoms of phosphoribosyl pyrophosphate synthetase 1 (PRPS1) deficiency diseases have been reported to be alleviated by medication. In the present study, we report biochemical data that favor PRPS1 deficiency-related hearing loss as a potential target for pharmaceutical treatment. Methods: We recruited 42 probands from subjects aged less than 15 years with a moderate degree of nonsyndromic autosomal-recessive or sporadic sensorineural hearing loss (SNHL) in at least one side. Molecular genetic testing, including targeted exome sequencing (TES) of 129 genes for deafness, and in silico prediction were performed. Results: A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in X-linked recessive inheritance from one Korean multiplex SNHL family. Subsequent measurement of in vitro enzymatic activities of PRPS1 from erythrocytes of affected and unaffected family members, as well as unrelated normal controls, confirmed a pathogenic role of this variant. In detail, compared to normal hearing controls (0.23–0.26 nmol/ml/h), the proband, the affected sibling and their normal hearing mother demonstrated a significantly decreased PRPS1 enzymatic activity (0.07, 0.03 and 0.11 nmol/ml/h, respectively). This novel loss-of-function mutation of PRPS1 (p.A82P) is the ninth and sixth most reported mutation in the world and in Asia, respectively. Conclusions: DFNX1 was found to account for approximately 2.4% (1/42) of moderate SNHL in a Korean pediatric population. Confirmation of PRPS1 activity deficiency and an audiologic phenotype that initially begins in a milder form of SNHL, as in our family, should indicate the need for rigorous genetic screening as early as possible.

KW - DFNX1 (X-linked nonsyndromic sensorineural deafness type 1)

KW - Korean

KW - p.A82P

KW - PRPS1

KW - S-adenosylmethionine (SAM)

UR - http://www.scopus.com/inward/record.url?scp=85007415418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007415418&partnerID=8YFLogxK

U2 - 10.1002/jgm.2935

DO - 10.1002/jgm.2935

M3 - Article

C2 - 27886419

AN - SCOPUS:85007415418

VL - 18

SP - 353

EP - 358

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 11-12

ER -